Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type 1 selected

Type

Guidance programme

Showing 1151 to 1200 of 2013

TitleReference numberPublishedLast updated
Tests in secondary care to identify people at high risk of ovarian cancerHTG453
Regorafenib for previously treated unresectable or metastatic gastrointestinal stromal tumoursTA488
Total distal radioulnar joint replacement for symptomatic joint instability or arthritisHTG451
Extracranial to intracranial bypass for intracranial atherosclerosisHTG452
Aflibercept for treating choroidal neovascularisationTA486
Sarilumab for moderate to severe rheumatoid arthritisTA485
Sinusitis (acute): antimicrobial prescribingNG79
Cataracts in adults: managementNG77
Cystic fibrosis: diagnosis and managementNG78
Hepatitis B (chronic): diagnosis and managementCG165
Immunosuppressive therapy for kidney transplant in adultsTA481
Immunosuppressive therapy for kidney transplant in children and young peopleTA482
Tofacitinib for moderate to severe rheumatoid arthritisTA480
Child abuse and neglectNG76
Autologous chondrocyte implantation for treating symptomatic articular cartilage defects of the kneeTA477
Brentuximab vedotin for treating relapsed or refractory systemic anaplastic large cell lymphomaTA478
Reslizumab for treating severe eosinophilic asthmaTA479
Faltering growth: recognition and management of faltering growth in childrenNG75
Intramuscular diaphragm stimulation for ventilator-dependent chronic respiratory failure caused by motor neurone diseaseHTG450
Cetuximab and panitumumab for previously untreated metastatic colorectal cancerTA439
Intermediate care including reablementNG74
Type 2 diabetes: prevention in people at high riskPH38
High-intensity focused ultrasound for symptomatic breast fibroadenomaHTG449
Ab externo canaloplasty for primary open-angle glaucomaHTG448
Pembrolizumab for treating PD-L1-positive non-small-cell lung cancer after chemotherapyTA428
Pembrolizumab for treating advanced melanoma after disease progression with ipilimumabTA357
Pembrolizumab for advanced melanoma not previously treated with ipilimumabTA366
Fertility problems: assessment and treatmentCG156
Sorafenib for treating advanced hepatocellular carcinomaTA474
Dimethyl fumarate for treating moderate to severe plaque psoriasisTA475
Paclitaxel as albumin-bound nanoparticles with gemcitabine for untreated metastatic pancreatic cancerTA476
Psoriasis: assessment and managementCG153
Cetuximab for treating recurrent or metastatic squamous cell cancer of the head and neckTA473
Vitamin D: supplement use in specific population groupsPH56
Methylnaltrexone bromide for treating opioid-induced constipation (terminated appraisal)TA468
Idelalisib with ofatumumab for treating chronic lymphocytic leukaemia (terminated appraisal)TA469
Radiofrequency treatment for haemorrhoidsHTG447
Holoclar for treating limbal stem cell deficiency after eye burnsTA467
Pemetrexed for the maintenance treatment of non-small-cell lung cancerTA190
Developmental follow-up of children and young people born pretermNG72
Cabozantinib for previously treated advanced renal cell carcinomaTA463
Baricitinib for moderate to severe rheumatoid arthritisTA466
moorLDI2-BI: a laser doppler blood flow imager for burn wound assessmentHTG257
Nutrition support for adults: oral nutrition support, enteral tube feeding and parenteral nutritionCG32
Adalimumab and dexamethasone for treating non-infectious uveitisTA460
Roflumilast for treating chronic obstructive pulmonary diseaseTA461
Nivolumab for treating relapsed or refractory classical Hodgkin lymphomaTA462
Transcatheter aortic valve implantation for aortic stenosisHTG446
Parkinson's disease in adultsNG71
Constipation in children and young people: diagnosis and managementCG99

Results per page

  1. 10
  2. 25
  3. 50
  4. All